Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 271
- Registration Number
- NCT01887340
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val de Marne, France
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
Phase 3
Completed
- Conditions
- Head Neck Cancer Squamous Cell Recurrent
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 82
- Registration Number
- NCT01884623
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
Phase 1
Completed
- Conditions
- Recurrent Low-grade GliomasRefractory Low-grade Gliomas
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 35
- Registration Number
- NCT01884922
- Locations
- 🇨🇭
Swiss Pediatric Oncology Group, Bern, Switzerland
🇳🇱Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
🇬🇧Cancer Research UK Clinical Trials Unit School of Cancer Sciences University of Birmingham, Edgbaston, Birmingham, United Kingdom
A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies
Not Applicable
Completed
- Conditions
- Metastatic Cancer
- Interventions
- Procedure: Biopsy
- First Posted Date
- 2013-05-17
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 303
- Registration Number
- NCT01856296
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Phase 3
Active, not recruiting
- Conditions
- Low Risk Differentiated Thyroid Cancer
- Interventions
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 776
- Registration Number
- NCT01837745
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Identification of Early Markers of Response and Resistance to Trastuzumab
Not Applicable
Completed
- Conditions
- Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
- Interventions
- Other: Blood test
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 25
- Registration Number
- NCT01834950
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Peripheral Primitive Fibromatosis
Not Applicable
- Conditions
- Peripheral Primitive Fibromatosis
- Interventions
- Other: MRI
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT01801176
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
Not Applicable
Completed
- Conditions
- Metastatic Castration Resistant Prostate Cancer Patients
- Interventions
- Other: metastasis biopsy
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 55
- Registration Number
- NCT01786031
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France
Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab
Phase 2
Terminated
- Conditions
- Patients With Gastric Peritoneal Carcinomatosis
- Interventions
- First Posted Date
- 2013-02-06
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 26
- Registration Number
- NCT01784900
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France
Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer
Phase 2
Terminated
- Conditions
- Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated
- Interventions
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 3
- Registration Number
- NCT01715363
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France
© Copyright 2025. All Rights Reserved by MedPath